Warfarin reversal: Difference between revisions
| Line 21: | Line 21: | ||
#Give [[Vitamin K]] 5-10mg IV INR will decrease over 24-48 hours (small risk of anaphylaxis with IV Vit K) | #Give [[Vitamin K]] 5-10mg IV INR will decrease over 24-48 hours (small risk of anaphylaxis with IV Vit K) | ||
#Give 4 Factor Prothrombin Complex Concentrate (PCC) | #Give 4 Factor Prothrombin Complex Concentrate (PCC) | ||
#If no PCC then give 2 unites Fresh Frozen Plasma | #If no PCC then give 2 unites [[Fresh Frozen Plasma]] | ||
:(no benefit to combining PCC and FFP | :(no benefit to combining PCC and [[FFP]] | ||
'''''Consult cardiology in conjunction with hematology if patient has prosthetic valve''''' | '''''Consult cardiology in conjunction with hematology if patient has prosthetic valve''''' | ||
Revision as of 08:00, 5 February 2014
Background
- Vitamin K
- Oral route is preferred over subcutaneous route: superior efficacy
- Intravenous route carries rare but serious risk of anaphylaxis
- Only give for patient with:
- Life-threatening bleeding
- INR >20
- Symptomatic patient poisoned by suicidal ingestion of warfarin or rodenticide
Excessive Anticoagulation Treatment [1]
INR ≤ 10 No Bleeding
- Hold Coumadin
- Resume Coumadin at lower dose once INR therapeutic
INR > 10 No Bleeding
- Hold Coumadin
- Vitamin K 2.5 mg oral
Major Bleeding
- Stop warfarin
- Give Vitamin K 5-10mg IV INR will decrease over 24-48 hours (small risk of anaphylaxis with IV Vit K)
- Give 4 Factor Prothrombin Complex Concentrate (PCC)
- If no PCC then give 2 unites Fresh Frozen Plasma
- (no benefit to combining PCC and FFP
Consult cardiology in conjunction with hematology if patient has prosthetic valve
See Also
Source
- ↑ Holbrook A, et al; American College of Chest Physicians. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141